- জেনেরিক নাম
- Letrozole
- শক্তি
- 2.5 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- The ACME Laboratories Ltd.
৳ ৩৯.২ ৳ ৪০.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
বাংলাদেশে Fezol 2.5 mg Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Letrozole আছে (২.৫ mg)। Fezol-এর সাথে Letrozole-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। Fezol-এর প্রতি ইউনিটের দাম ৪০ টাকা। Fezol প্রস্তুত করেছে The ACME Laboratories Ltd। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Letrozole-এর ৭টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। ইউনিট দামের হিসেবে Fezol এগুলোর মধ্যে সবচেয়ে কম দামিদের একটি। সবচেয়ে কম দাম Ovazol 2.5 mg Tablet-এর, প্রতি ইউনিট ৳ ৪০.০০।
Fezol 2.5 mg tablet is a hormonal chemotherapy medicine. Its active ingredient is letrozole, which works by reducing the amount of estrogen the body produces. Some breast cancers need estrogen to grow, so lowering estrogen levels takes away that growth stimulus. Fezol is used for the first-line treatment of advanced or metastatic breast cancer in women who have gone through menopause, when the cancer is hormone receptor positive or the receptor status is unknown. It comes as a tablet in a 2 x 5 pack. Your doctor will decide whether this medicine is suitable for you and how long treatment should continue.
Fezol is used to treat advanced or metastatic breast cancer in women who have reached menopause, where the cancer is hormone receptor positive or the receptor status is not known. It is given as first-line treatment in this setting. It is not for women who have not yet reached menopause. Only your doctor can confirm whether your type of breast cancer is likely to respond to this medicine, so discuss your treatment plan with your doctor.
Fezol is a tablet that is taken by mouth. Your doctor decides the dose, how often you take it and how long the course lasts, and you should follow those instructions exactly. Do not change the dose or stop the medicine on your own. If you are unsure how to take it, or if you miss a tablet, ask your doctor or pharmacist for advice. Store it below 30°C, away from light and moisture, and keep it out of the reach of children.
Side effects with letrozole are usually mild to moderate and only rarely severe enough for treatment to be stopped. Many are linked to the low estrogen levels the medicine causes. The most commonly reported ones include muscle and joint pain, headache, tiredness, nausea, shortness of breath, swelling of the feet or legs, cough, constipation, vomiting, chest pain, diarrhoea, rash, stomach pain, indigestion and loss of appetite. Dizziness, weight gain and itching are seen less often. Tell your doctor about any side effect that troubles you.
Fezol must not be used during pregnancy or breastfeeding, or by women who have not yet reached menopause. It is also not for people with a known or suspected allergy to letrozole or other aromatase inhibitors, or with severe liver problems. Before starting it, tell your doctor about any liver or kidney problems, all other medicines you take, and any allergies. Your doctor will weigh the risks and benefits for your situation. Do not start, stop or change the medicine without medical advice, and ask your doctor about any concerns.
Letrozole is the generic name of the active ingredient in Fezol. It is a nonsteroidal aromatase inhibitor, a type of hormonal chemotherapy medicine. The brand name Fezol is simply the name given by the manufacturer, The ACME Laboratories Ltd., to its own 2.5 mg tablet of letrozole.
Fezol is a hormonal chemotherapy tablet containing letrozole. It is used for the first-line treatment of advanced or metastatic breast cancer in post-menopausal women whose cancer is hormone receptor positive or of unknown receptor status. It works by lowering estrogen production. Your doctor will decide if it suits your condition.
No. Fezol is not to be used during pregnancy or while breastfeeding, and it is not for women who have not reached menopause. If you are pregnant, think you may be pregnant, or are breastfeeding, tell your doctor before taking this medicine. Ask your doctor about effective contraception during treatment.
The listed price is ৳ ৪০.০০. Prices can change, so check with your pharmacy for the current price. Your doctor or pharmacist can also advise you on the pack and any available alternatives.
৳ ৩৯.২ ৳ ৪০.০০ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৮ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Letrozole is indicated for the first-line treatment of advanced/metastatic breast cancer (hormone receptor positive or receptor status unknown) in post-menopausal women.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Mechanism of Action: Letrozole is a potent and highly specific nonsteroidal aromatase inhibitor. It inhibits the aromatase enzyme by competitively binding to the haem of the cytochrome P450 subunit of the enzyme, resulting in a reduction of estrogen biosynthesis in all tissues. Letrozole exerts its antitumor effect by depriving estrogen-dependent breast cancer cells of their growth stimulus. In postmenopausal women, estrogens are derived mainly from the action of the aromatase enzyme, which coverts adrenal androgens primarily androstenedione and testosterone-to oestrone (E1) and oestradiol (E2). The suppression of estrogen biosynthesis in the peripheral tissues and the malignant tissues can be achieved by specifically inhibiting the aromatase enzyme.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
The recommended dose of Letrozole is 2.5 mg once daily. Treatment with Letrozole should continue as long as tumor response is seen. The drug should be discontinued if tumor stops responding as judged by tumor progression. For elderly patients, no modification of the normal adult dosage regimen is necessary. No dosage adjustment is required for patients with mild to moderate hepatic impairment or renal impairment.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Clinical interaction studies with cimetidine and warfarin indicated that the co-administration of letrozole with these drugs does not result in clinically significant drug reactions, even through cimetidine is a known inhibitor of one of the cytochrome P450 isoenzymes capable of metabolising letrozole in vitro.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Letrozole is contraindicated in known or suspected hypersensitivity to letrozole, other aromatase inhibitors, or to any of their ingredients. It is contraindicated during pregnancy, lactation and in pre-menopausal women. It is also contraindicated in severe hepatic dysfunction.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Adverse events associated with letrozole are generally mild to moderate and rarely severe enough to require discontinuation. Many can be attributed to either the underlying disease or the normal pharmacological consequence of oestrogen deprivation (hot flushes, hair thinning). The most frequently reported adverse events are musculoskeletal pain, arthralgia, headache, fatigue, nausea, dyspnoea, peripheral oedema, coughing, constipation, vomiting, chest pain, viral infection, diarrhoea, rash, abdominal pain, dyspepsia and anorexia. Dizziness, weight increase and pruritus are less commonly seen.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Oral administration of letrozole in pregnant rats resulted in teratogenicity and maternal toxicity at 0.03 mg/kg. Embryotoxicity and foetotoxicity were seen at doses >0.003 mg/kg and there was an increase in the incidence of foetal malformation among the animals treated. However, there are no adequate and well-controlled studies of letrozole in pregnant women and its use in these patients is not recommended. It is not known whether letrozole is excreted in human milk. Because many drugs are excreted in human milk, letrozole should not be administered to a nursing woman.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In breast cancer patients with moderate hepatic dysfunction, no dosage adjustment is necessary, but caution is recommended since letrozole elimination depends mainly on intrinsic metabolic clearance. Renal impairment (calculated creatinine clearance: 20 to 50 ml/min) did not affect steady-state plasma letrozole concentration at a dose of 2.5 mg or 5 mg. Hence, no dose adjustment is necessary for such renal function impairment. It is anticipated that letrozole could be removed from blood by dialysis since it is weakly bound to plasma proteins. The potential risks and benefits to such patients should be considered carefully before prescribing letrozole. In some cases, fatigue and dizziness have been observed with the use of letrozole. Patients should therefore, be advised that their physical and/or mental abilities required for operating machinery or driving a car may be impaired.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is no clinical experience of overdosage. There is no specific antidote to letrozole. Since letrozole is not highly protein-bound, dialysis may be helpful. Emesis may be induced if the patient is alert. In general, supportive care and frequent monitoring of vital signs is appropriate.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।